A note from the Editor: At US Income Report, we keep an eye out for favorable circumstances we believe will interest our readers. The following is one such message from one of our colleagues I think you’ll appreciate.
Dear Fellow Investor, On December 12, ex-Wall Street CEO Dylan Jovine wrote that "M & A activity will start accelerating soon" in the biotech sector. The very next day, Pfizer bought Arena Pharmaceuticals, sending shares up 83% in one day. And on December 22, Novartis bought Gyroscope Therapeutics in a $1.6 billion deal. Here's the next small biotech he thinks gets taken over ››› All the best, Simmy Adelman Editor, Behind the Markets
You received this email as a result of your consent to receive 3rd party offers at our another website. This email was sent by: US Income Report, LLC 6130 West Flamingo Road PMB 4053 Las Vegas, NV, 89103, US This ad is sent on behalf of Behind The Markets, 4181 NW 1st Ave #8, Boca Raton, FL 33431. If you would like to unsubscribe from receiving offers from Behind The Markets please click here. Don’t forget to whitelist us. Follow instructions. Thinking about unsubscribing? We hope not! But, if you must, the link is below. Update Profile | Manage Subscriptions | Unsubscribe | Terms & Conditions | Privacy Policy